Assessment of alendronate and dietary treatment in the management of feline idiopathic ionised hypercalcaemia and ionised hypercalcaemia associated with chronic kidney disease: 29 cases (2016‐2022)

Objectives This retrospective cohort multicentre study aimed to characterise the signalment, clinicopathologic data, complications and the association between treatment and outcome (the reduction in ionised calcium concentration) in cats with idiopathic or chronic kidney disease‐associated ionised h...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of small animal practice 2024-09, Vol.65 (9), p.682-693
Hauptverfasser:	Rzeszutek, U., Allerton, F., Au, C., Bras, I., Briggs, A., Broome, H., Gamston, T., Parton, S., Raj, J., Rossell, G. M., Russell, O., Sparks, T., Bazelle, J.
Format:	Artikel
Sprache:	eng
Schlagworte:	Alendronate - administration & dosage Alendronate - therapeutic use Alendronic acid Animals Bisphosphonates blood serum Bone Density Conservation Agents - administration & dosage Bone Density Conservation Agents - adverse effects Bone Density Conservation Agents - therapeutic use calcium Calcium (dietary) Calcium - blood Calcium signalling Cat Diseases - diet therapy Cat Diseases - drug therapy Cats Cohort Studies Diet Female Hypercalcemia Hypercalcemia - drug therapy Hypercalcemia - veterinary ionization Jaw Kidney diseases kidneys Male Medical records Medical treatment Necrosis nutritional intervention Osteonecrosis Renal Insufficiency, Chronic - complications Renal Insufficiency, Chronic - veterinary Retrospective Studies small animal practice Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!